Singal AG, Rakoski MO, Salgia R, Pelletier S, Welling TH, Fontana RJ, et al. The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre. Aliment Pharm Ther. 2010;31:625–33.

Article  CAS  Google Scholar 

Koerkamp BG, Clavien PA, Polak WG. Surgical resection for intrahepatic cholangiocarcinoma-can we really improve survival by resecting more lymph nodes? J Hepatol. 2023;78:235–7.

Article  PubMed  Google Scholar 

Cai J, Cui Z, Zhou J, Zhang B, Lu R, Ding Y, et al. METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10. Cancer Cell Int. 2022;22:385.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wang X, Wang G, Wu Z, Dong Y, Shi Y, Yang F, et al. Exosomal circ-PTPN22 and circ-ADAMTS6 mark T cell exhaustion and neutrophil extracellular traps in Asian intrahepatic cholangiocarcinoma. Mol Ther Nucleic Acids. 2023;31:151–63.

Article  PubMed  CAS  Google Scholar 

Ding DY, Gan XJ, Zhang JN, Hou GJ, Tao QF, Sun DP, et al. Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma. Br J Cancer. 2023;128:907–17.

Article  PubMed  CAS  Google Scholar 

Sae-Fung A, Mutirangura A, Jitkaew S. Identification and validation of a novel ferroptosis-related gene signature for prognosis and potential therapeutic target prediction in cholangiocarcinoma. Front Immunol. 2022;13:1051273.

Article  PubMed  CAS  Google Scholar 

Uijterwijk BA, Lemmers DHL, Bolm L, Luyer M, Koh YX, Mazzola M, et al. Long-term outcomes after laparoscopic, robotic, and open pancreatoduodenectomy for distal cholangiocarcinoma: an international propensity score-matched cohort study. Ann Surg. 2023;278:e570–e579.

Article  PubMed  Google Scholar 

Zhong X, Ji C, Ren D, Ke A, Yang Z. Circular RNA circEIF3C promotes intrahepatic cholangiocarcinoma progression and immune evasion via the miR-34a-5p/B7-H4 axis. Genes Dis. 2023;10:370–2.

Article  PubMed  CAS  Google Scholar 

Shridhar R, Blinn P, Huston J, Meredith KL. Outcomes of adjuvant radiation therapy after chemotherapy in resected extrahepatic cholangiocarcinoma: A National Cancer Database analysis. Cancer. 2023;129:890–900.

Article  PubMed  CAS  Google Scholar 

Jones O, Cheng X, Murthy SRK, Ly L, Zhuang T, Basadonna G, et al. The synergistic effect of Canady Helios cold atmospheric plasma and a FOLFIRINOX regimen for the treatment of cholangiocarcinoma in vitro. Sci Rep. 2021;11:8967.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Louis C, Ferlier T, Leroux R, Pineau R, Desoteux M, Papoutsoglou P, et al. TGFbeta-induced circLTBP2 predicts a poor prognosis in intrahepatic cholangiocarcinoma and mediates gemcitabine resistance by sponging miR-338-3p. JHEP Rep. 2023;5:100900.

Article  PubMed  PubMed Central  Google Scholar 

Lee CK, Chon HJ, Cheon J, Lee MA, Im HS, Jang JS, et al. Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19-14). Lancet Gastroenterol Hepatol. 2023;8:56–65.

Article  PubMed  Google Scholar 

Eptaminitaki GC, Stellas D, Bonavida B, Baritaki S. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: from prediction to druggability. Drug Resist Updat. 2022;65:100866.

Article  PubMed  CAS  Google Scholar 

Tan H, Zhang S, Zhang J, Zhu L, Chen Y, Yang H, et al. Long non-coding RNAs in gastric cancer: new emerging biological functions and therapeutic implications. Theranostics. 2020;10:8880–902.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wang J, Tan L, Yu X, Cao X, Jia B, Chen R, et al. lncRNA ZNRD1-AS1 promotes malignant lung cell proliferation, migration, and angiogenesis via the miR-942/TNS1 axis and is positively regulated by the m(6)A reader YTHDC2. Mol Cancer. 2022;21:229.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhang Y, Xu L, Ren Z, Liu X, Song J, Zhang P, et al. LINC01615 maintains cell survival in adaptation to nutrient starvation through the pentose phosphate pathway and modulates chemosensitivity in colorectal cancer. Cell Mol Life Sci. 2022;80:20.

Article  PubMed  PubMed Central  Google Scholar 

Zhou Y, Xu Z, Wang Y, Song Q, Yin R. LncRNA MALAT1 mediates osteogenic differentiation in osteoporosis by regulating the miR-485-5p/WNT7B axis. Front Endocrinol. 2022;13:922560.

Article  Google Scholar 

Liu Y, Choy MK, Abraham S, Tenin G, Black GC, Keavney BD. Atrial septal defect (ASD) associated long non-coding RNA STX18-AS1 maintains time-course of in vitro cardiomyocyte differentiation. Genes Dis. 2023;10:1150–3.

Article  PubMed  CAS  Google Scholar 

Kang H, Huang D, Li H, Deng X, Liu S, Gou W, et al. lncNALT knockdown ameliorates hypertensive retinopathy via PTEN/PI3K/AKT pathway. Bioengineered. 2022;13:15003–12.

Article  PubMed  CAS  Google Scholar 

Duwe L, Munoz-Garrido P, Lewinska M, Lafuente-Barquero J, Satriano L, Hogdall D, et al. MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells. J Hepatol. 2023;78:364–75.

Article  PubMed  CAS  Google Scholar 

Lu Y, Li S, Song S, Wang L, Chen Y, Jiang X, et al. A lncRNA MEG3 variant enhances telomerase activity by increasing DNA damage repair ability in human liver cancer stem cells. Genes Dis. 2023;10:1763–6.

Article  PubMed  CAS  Google Scholar 

Zhang Y, Fang Y, Ma L, Xu J, Lv C, Deng L, et al. LINC00857 regulated by ZNF460 enhances the expression of CLDN12 by sponging miR-150-5p and recruiting SRSF1 for alternative splicing to promote epithelial-mesenchymal transformation of pancreatic adenocarcinoma cells. RNA Biol. 2022;19:548–59.

Article  PubMed  CAS  Google Scholar 

Zhu L, Yang X, Feng J, Mao J, Zhang Q, He M, et al. CYP2E1 plays a suppressive role in hepatocellular carcinoma by regulating Wnt/Dvl2/beta-catenin signaling. J Transl Med. 2022;20:194.

Article  PubMed  CAS  Google Scholar 

Ju Q, Zhao YJ, Ma S, Li XM, Zhang H, Zhang SQ, et al. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma. J Cancer Res Clin Oncol. 2020;146:1711–23.

Article  PubMed  CAS  Google Scholar 

Wu J, Zheng C, Wang Y, Yang Z, Li C, Fang W, et al. LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/miR-324-3p-SIRT5 axis in lung adenocarcinoma. Biomark Res. 2021;9:9.

Article  PubMed  Google Scholar 

Yang W, Zhou J, Zhang Z, Zhang K, Xu Y, Li L, et al. Downregulation of lncRNA APCDD1L-AS1 due to DNA hypermethylation and loss of VHL protein expression promotes the progression of clear cell renal cell carcinoma. Int J Biol Sci. 2022;18:2583–96.

Article  PubMed  CAS  Google Scholar 

Hao T, Xu J, Fang S, Jiang J, Chen X, Wu W, et al. Overexpression of ZNF460 predicts worse survival and promotes metastasis through JAK2/STAT3 signaling pathway in patient with colon cancer. J Cancer. 2021;12:3198–208.

Article  PubMed  CAS  Google Scholar 

Shao X, Zhong L, Chu X, Wan P, Chen S, Zhou Z, et al. ZNF460-regulated COMMD7 promotes acute myeloid leukemia proliferation via the NF-kappaB signaling pathway. Int J Med Sci. 2023;20:520–9.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhao D, Zhong G, Li J, Pan J, Zhao Y, Song H, et al. Targeting E3 ubiquitin ligase WWP1 prevents cardiac hypertrophy through destabilizing DVL2 via inhibition of K27-linked ubiquitination. Circulation. 2021;144:694–711.

Article  PubMed  CAS  Google Scholar 

Deng YZ, Yao F, Li JJ, Mao ZF, Hu PT, Long LY, et al. RACK1 suppresses gastric tumorigenesis by stabilizing the beta-catenin destruction complex. Gastroenterology. 2012;142:812–23.e15.